Oncorena AB
556864-0808ActiveDeveloping a breakthrough treatment for metastatic renal cancer using orellanine.
Overview
- 1–4
- Employees
- ≤1K SEK
- Revenue
- 2011
- Founded
Key Decision Makers
Börje Haraldsson
CEO
Susanna Dahlgren
Chief Operating Officer
Åsa Holmgren
Head of Regulatory Affairs
Description
Oncorena AB is a Swedish pharmaceutical company founded in 2011, currently headquartered in Lund. Their primary mission is to transform a natural substance into a breakthrough treatment for patients with metastatic renal cancer. The company is developing ONC175, the synthetically produced active ing...
Tags
Keywords
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556864080801
Decision Makers
3 contacts in FunnelfeedrBörje Haraldsson
CEO
Susanna Dahlgren
Chief Operating Officer
Åsa Holmgren
Head of Regulatory Affairs
Similar Companies
20 similar companies in FunnelfeedrAbarceo Pharma AB
5–9 employeesDeveloping novel small molecule therapeutics targeting VDAC1 for diabetes.
Lokon Pharma AB
10–19 employeesDeveloping novel gene engineering vectors for cancer immunotherapy.
ALLUCENT (NL) B.V.
5–9 employeesGlobal full-service CRO accelerating therapy development for small biotechs.
Ascelia Pharma AB
Biotech developing novel orphan oncology drugs for unmet needs.
Ribocure Pharmaceuticals AB
20–49 employeesClinical stage biotech developing cutting-edge RNA therapeutics for rare diseases.
Browse More
Oncorena AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo